Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2005-004809-29Phase 3Active
Phase 3, open-label, single-arm trial of atazanavir and ritonavir in human immunodeficiency virus infection (HIV), sponsored by Papa Giovanni XXIII Hospital. Primary endpoint: Primary pharmacokinetic parameters of atazanavir and ritonavir. Started Sep 2007; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2005-004809-29.